BioCentury
ARTICLE | Clinical News

Icatibant regulatory update

July 26, 2004 7:00 AM UTC

FDA granted Fast Track designation for Icatibant, a bradykinin receptor antagonist, to treat hereditary angioedema (HAE). ...